Search Results 1-10 of 16065 for Proto-oncogene
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.
10 issue of Cancer Cell the discovery of two oncogenes that work together to sustain a population of cells in lung squamous cell carcinoma, which may be ...
“We discovered that in these particular cases, the cancer exhibited a MET oncogene amplification, which creates a hostile environment for immunotherapy,” says ...
Interpret technology — immunostains, RET proto-oncogene, DNA ploidy, reverse transcription-polymerase chain reaction (RT-PCR), gene profiling and implications ...
... proto-oncogene 1. Gastroenterology. 2023 Jul; 165 (1):228-43.e2; Calvisi DF, Boulter L, Vaquero J, Saborowski A, Fabris L, Rodrigues PM, Coulouarn C, Castro ...
Bidirectional sequence analysis was performed to test for the presence of a mutation in exons 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene and was ...
This oncogene creates an immunosuppressive tumor microenvironment that confers resistance to immune checkpoint inhibitor therapy, a promising treatment modality ...
That's according to new Mayo Clinic research. The findings, published this month in Oncogene, indicate that increasing the expression of the PD-L1 protein in ...
Found PKCiota activates a second oncogene, known as SOX2, to stimulate cancer stem cell growth in lung squamous cell carcinoma. Dr. Fields says the current ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.